OBJECTIVE. The purpose of this article is to summarize the evidence regarding the role of
FDG PET/CT in treatment response assessment and surveillance of lung cancer and to …

Lung cancer remains a leading cause of cancerrelated deaths worldwide, accounting for
approximately 224,390 new patients and 158,080 deaths in 2016, according to the …

The optimal methodology for defining response with 18F-FDG PET after curative-intent
chemoradiation for non–small cell lung cancer (NSCLC) is unknown. We compared survival …

Background: Metabolic information provided by 18F-FDG PET/CT are useful for initial
staging, therapy planning, response evaluation, and to a lesser extent for the follow-up of …

This review covers the state-of-the-art imaging in therapy assessment and surveillance of
lung cancer with focus on the utility of fluorine-18 fluorodeoxyglucose positron emission …

Background The purpose of this study is to determine whether a qualitative approach or a
semi-quantitative approach provides the most robust method for early response evaluation …

Background and purpose This study tested the hypotheses that 1) changes in mid-treatment
fluorodeoxyglucose (FDG)-positron emission tomography (PET) parameters are predictive of …

Objective: To assess the predictive and prognostic value of progressive metabolic disease
(PMD) by the use of early 18Fluorodeoxyglucose positron emission tomography (18FDG …

Objective The objective of this study was to investigate the correlation between dual-energy
computed tomography (DECT)–based iodine quantitation and fluorine-18 …

Treatment response assessment in lung cancer is crucial in the management strategy and
outcome of patients. Accurate treatment response assessment can guide the treating …